Education
About Us
Working with TipRanks
Follow Us
Robert M Plenge Insider Profile
4 Followers
Robert M Plenge, Director at Translate Bio, holds ― shares in Translate Bio (Ticker: ~TBIO), holds 18.13K shares in Bristol-Myers Squibb (Ticker: BMY). Most recently, Robert M Plenge ― shares of Translate Bio on ― for an estimated value of ―.
Robert M Plenge Translate Bio (~TBIO)Director
Translate Bio (~TBIO)
Director
Not Ranked
Robert M Plenge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, Chief Research Officer
Roles that Robert M Plenge holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Robert M Plenge
Robert M Plenge's Trading History
Translate Bio
―
―
―
―
Bristol-Myers Squibb
Mar 12, 2025
EVP, Chief Research Officer
Uninformative Buy
482.48K
$1.13M
List of latest transactions for each holding click on a transaction to see Robert M Plenge's performance on stock
You May Also Like
Robert M Plenge insider profile FAQ
What is the percentage of profitable transactions made by Robert M Plenge?
The percentage of profitable transactions made by Robert M Plenge is ―.
What is the average return per transaction made by Robert M Plenge?
The average return per transaction made by Robert M Plenge is ―.
What stocks does Robert M Plenge hold?
Robert M Plenge holds: ~TBIO, BMY stocks.
What was Robert M Plenge’s latest transaction?
Robert M Plenge latest transaction was an Uninformative Buy of ―.
What was Robert M Plenge's most profitable transaction?
Robert M Plenge’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Robert M Plenge's role in Translate Bio?
Robert M Plenge's role in Translate Bio is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.